Pfizer Inc.

Pfizer Inc.
Name	Pfizer Inc.
Type	Public
Industry	Pharmaceuticals
Founded	1849
Founder	Charles Pfizer, Charles F. Erhart
Headquarters	Brooklyn, New York City, United States
Area served	Global
Key people	Albert Bourla, Ian Read, Andrew Witty
Products	Pharmaceuticals, Vaccines, Biologics
Revenue	US$51.8 billion (2022)
Num employees	79,000 (2023)

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation headquartered in Brooklyn, New York City. Founded in 1849 by Charles Pfizer and Charles F. Erhart, it grew from an organic-chemical manufacturer into one of the largest global developers of prescription medicines, vaccines, and consumer healthcare products. Pfizer's operations span research sites, manufacturing plants, and commercial offices across regions including United States, Europe, Asia, and Latin America.

History

Pfizer traces origins to its 1849 founding in Brooklyn by Charles Pfizer and Charles F. Erhart, initially producing santonic acid and other chemicals for New York City markets, later expanding into antibiotics with mass production of penicillin linked to wartime contracts and collaborations with U.S. War Department, U.S. Army, and industrial partners like E.R. Squibb and Sons. Growth accelerated through 20th-century acquisitions including Warner-Lambert, Wyeth, and strategic alliances with AstraZeneca and Merck & Co. (notably joint ventures), leading to diversification into vaccines via purchase of Wyeth and consumer healthcare spinoffs connected to GlaxoSmithKline and Johnson & Johnson. In the 21st century Pfizer pursued major mergers and pipeline reshaping under CEOs such as Jeffrey B. Kindler, Ian Read, and Albert Bourla, culminating in high-profile development of a COVID-19 vaccine in partnership with BioNTech and emergency use authorizations involving regulatory agencies like the U.S. Food and Drug Administration and European Medicines Agency.

Corporate Affairs

Pfizer's corporate governance involves a board with directors drawn from firms such as Goldman Sachs, BlackRock, and affiliations with academic institutions like Harvard University and Johns Hopkins University. Headquarters relocated through corporate history from Brooklyn to Manhattan and operational centers in Groton, Connecticut and Collegeville, Pennsylvania. Major shareholders include institutional investors Vanguard Group, State Street Corporation, and BlackRock. Pfizer participates in trade associations including PhRMA and engages with regulatory bodies such as the U.S. Food and Drug Administration, European Medicines Agency, and national agencies in China and India.

Research and Development

Pfizer operates research sites and collaborations with academic partners such as University of Oxford, Harvard Medical School, and Columbia University, and works with biotech firms including BioNTech, Moderna, and Amgen on platform technologies like mRNA, monoclonal antibodies, and small-molecule therapeutics. R&D strategy focuses on oncology, immunology, rare disease, and vaccines, with programs utilizing technologies from CRISPR research groups, partnerships with Genentech and licensing deals with AstraZeneca. Clinical development spans Phases I–III overseen by institutional review boards and regulatory submissions to agencies including the U.S. Food and Drug Administration and European Medicines Agency.

Products and Services

Pfizer's product portfolio includes prescription medicines such as Vioxx competitor drugs, oncology agents, immunology biologics, and the widely known Viagra. The company developed the BNT162b2 COVID-19 vaccine in partnership with BioNTech, distributed under emergency authorizations via programs coordinated with World Health Organization and national immunization campaigns in United States, United Kingdom, and Germany. Other notable products have included antibiotics like penicillin derivatives, vaccines acquired with Wyeth (e.g., Prevnar-related technologies), and consumer health lines formerly co-owned with GlaxoSmithKline and Pfizer Consumer Healthcare ventures. Services include manufacturing, global distribution, pharmacovigilance, and patient-assistance programs administered in coordination with healthcare systems such as National Health Service (England) and payer networks in United States.

Financial Performance

Pfizer is listed on the New York Stock Exchange and included in indices such as the S&P 500 and Dow Jones Industrial Average during various periods. Revenue and profitability have reflected product cycles, patent cliffs, and major one-time events like the COVID-19 vaccine rollout, with reported revenues near US$51.8 billion in 2022 and significant operating cash flows reinvested in R&D and acquisitions. Financial operations interact with auditors and banks including PricewaterhouseCoopers and JPMorgan Chase, and Pfizer issues bonds on capital markets managed by underwriting firms such as Goldman Sachs.

Controversies and Legal Issues

Pfizer has faced litigation and regulatory scrutiny, including large settlements with the U.S. Department of Justice over marketing practices, patent disputes with companies like Teva Pharmaceutical Industries and Roche, and antitrust investigations in jurisdictions including the European Commission and United States Department of Justice. High-profile legal matters included disputes over drug pricing involving state attorneys general, product liability cases in multiple countries, and debates over intellectual property during the COVID-19 pandemic involving World Trade Organization discussions on patent waivers and access to medicines. Pfizer has also been involved in compliance investigations tied to international anti-corruption enforcement by agencies such as the U.S. Securities and Exchange Commission.

Category:Pharmaceutical companies Category:Companies based in New York City